Production Details-
| Composition | Acyclovir – 800 mg |
|---|---|
| Dosage | TABLET |
| Packing Size | 10×10 |
| Packing | Blister |
Acycop-800 is a high-potency antiviral medication meticulously formulated to combat a broad spectrum of viral infections. With its powerful action and rapid absorption, Acycop-800 is designed for superior therapeutic performance, ensuring faster recovery and symptom relief. Engineered with precision, it provides a reliable solution for patients dealing with conditions like herpes simplex, shingles, and other viral pathologies.
Each tablet of Acycop-800 contains:
Acyclovir IP 800 mg
Excipients: q.s.
This high dosage of Acyclovir makes Acycop-800 highly effective in inhibiting viral replication and curtailing disease progression.
The 800 mg strength ensures maximum antiviral action with minimal dosing frequency. This reduces pill burden and improves patient compliance.
Thanks to its advanced bioavailability profile, Acycop-800 starts working within hours of ingestion, ensuring swift suppression of viral DNA replication.
Acycop-800 is recommended by leading physicians and virologists for its consistent performance and safety record across all age groups (as advised by doctors).
Acycop-800 is widely prescribed for treating both initial and recurrent episodes of Herpes Simplex Virus type 1 and 2, including:
Genital herpes
Cold sores
Herpetic whitlow
In cases of shingles, Acycop-800 helps reduce the duration and severity of painful vesicular eruptions. It also lowers the risk of post-herpetic neuralgia, especially in elderly patients.
In pediatric and adult cases of chickenpox, Acycop-800 shortens the illness timeline and minimizes complications, especially in immunocompromised individuals.
Patients undergoing chemotherapy, organ transplant, or suffering from HIV/AIDS benefit from Acycop-800 as a preventive antiviral regimen, reducing the recurrence of opportunistic viral infections.
Acycop-800 targets viral DNA polymerase, preventing the synthesis of viral DNA. This halts the virus’s ability to replicate and spread within the body.
It is selectively activated in virus-infected cells, ensuring minimal toxicity to healthy cells and a favorable safety profile even in long-term therapy.
Adults: 800 mg 3-5 times daily, depending on indication and severity.
Children: Dosage varies based on body weight and medical necessity.
Always follow physician’s guidance for exact dosing instructions.
Treatment with Acycop-800 usually spans from 5 to 10 days. In chronic or recurrent cases, long-term suppressive therapy may be considered.
Acycop-800 is produced using AI-integrated pharmaceutical technology that ensures:
Accurate dosage uniformity
High purity levels
Enhanced tablet stability
It meets all WHO-GMP, USFDA, and ISO standards, ensuring every batch of Acycop-800 is safe, effective, and reliable.
Patients typically experience symptom relief within 24–48 hours of starting Acycop-800, reducing the overall disease burden.
Prolonged treatment with Acycop-800 has shown to reduce the frequency of recurrent herpes outbreaks.
Its easy-to-swallow tablet form and minimal side effects improve adherence, especially for long-term users.
Nausea
Headache
Dizziness
Mild abdominal discomfort
These effects are usually self-limiting and temporary.
Use with caution in patients with renal impairment
Avoid alcohol during treatment
Pregnant and lactating women should consult a physician before use
Acycop-800 may interact with certain nephrotoxic drugs or immunosuppressants. Always inform your doctor about all medications you’re taking.
Yes, Acycop-800 has been clinically tested for safety in long-term suppressive therapy under medical supervision.
Acycop-800 is not a cure but it significantly reduces outbreak frequency, severity, and viral shedding, improving quality of life.
Yes, Acycop-800 is a prescription-only medicine and must be taken under a doctor’s supervision.
Store Acycop-800 below 25°C, away from sunlight and moisture.
Keep out of reach of children.
Do not use past expiry date printed on the strip.
With its high active content and minimal fillers, Acycop-800 delivers unmatched performance in viral load suppression.
Prescribed in leading hospitals and clinics, Acycop-800 has earned the trust of healthcare providers for over a decade.
This page is generated with AI-precision and includes keyword-rich content, ideal for SEO rankings, customer education, and B2B marketing.
Acycop-800 is more than just a medicine; it is a benchmark in antiviral therapy. Whether you’re a healthcare provider, distributor, or a patient seeking dependable relief, Acycop-800 delivers consistent, proven, and high-impact results. With its AI-assisted manufacturing, robust antiviral mechanism, and optimized bioavailability, it remains a first-line choice for the treatment and management of viral infections.
